Please ensure Javascript is enabled for purposes of website accessibility

consumer health

Tylenol maker rebounds a day after Trump’s unfounded claims about its safety
Sep 23, 2025

Tylenol maker rebounds a day after Trump’s unfounded claims about its safety

Kenvue shares rebounded after Trump linked Tylenol to autism, claims disputed by the company and lacking new scientific evidence.

YOUR NEWS.
YOUR INBOX.
DAILY.

By subscribing you agree to our Privacy Policy.